← feed

Is NCT03311009 results overdue?

Yes — results are overdue. Primary completion was 2017-10-25; the FDAAA-801 reporting deadline (2018-10-25) passed 2796 days ago and no results are posted on ClinicalTrials.gov.

A Study With GLPG1972 in Osteoarthritis Subjects

NCT IDNCT03311009 ↗
SponsorLakefront Biotherapeutics NV (INDUSTRY)
Public issuerLakefront Biotherapeutics NV — LKFT (CIK 0001421876) best-effort name match, 95% conf — verify on EDGAR ↗
PhasePHASE1
StatusCOMPLETED
Primary completion2017-10-25 (ACTUAL)
Reporting deadline2018-10-25 (completion + 365d)
Days overdue2796
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 95fad212d7d34703… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03311009. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →